These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1309449)

  • 1. Prevalence of anti-hepatitis C virus antibodies among patients with alcoholic liver disease, supplemented by 4-RIBA.
    Laurent-Puig P; Dussaix E; Lecoz Y; Martes P; Buffet C
    Dig Dis Sci; 1992 Jan; 37(1):156-7. PubMed ID: 1309449
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of hepatitis C virus antibodies and hepatitis C virus RNA in patients with alcoholic liver disease.
    Nishiguchi S; Kuroki T; Yabusako T; Seki S; Kobayashi K; Monna T; Otani S; Sakurai M; Shikata T; Yamamoto S
    Hepatology; 1991 Dec; 14(6):985-9. PubMed ID: 1660025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of ELISA cut-off reduces HCV-Ab false-positivity in patients with HBV, HDV and alcoholic liver disease.
    Andreone P; Cursaro C; Miniero R; Stefanini GF; Sprovieri G; Gasbarrini G
    Ital J Gastroenterol; 1991 Dec; 23(9):567-8. PubMed ID: 1662091
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-HCV in heavy drinker].
    Yasuyama T
    Nihon Rinsho; 1991 Feb; 49(2):439-45. PubMed ID: 1849206
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatitis C and chronic alcoholic hepatopathy].
    Pagani A; Sala N; Zigliani P; Galante T
    Recenti Prog Med; 1994 Sep; 85(9):429-32. PubMed ID: 7938874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second-generation RIBA to confirm diagnosis of HCV infection.
    Lancet; 1991 Apr; 337(8746):912-3. PubMed ID: 1672986
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis B and C markers in alcoholic liver diseases].
    Varga L; Baranyai M; Löcsei Z; Toldy E; Brittig F
    Orv Hetil; 1994 Jul; 135(31):1691-4. PubMed ID: 7520558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and clinical importance of antibodies to hepatitis B virus and hepatitis C virus in patients with alcoholic liver disease].
    Goeser T; Theilmann L
    Z Gastroenterol; 1992 Apr; 30(4):279-80. PubMed ID: 1318621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies against hepatitis C virus. Experience with a second generation test].
    Garassini MA; Ortega F; Alvarado M; Valdés A; Díaz F; Dugarte I; Serrano L
    G E N; 1991; 45(3):183-9. PubMed ID: 1726913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody to hepatitis C virus and liver disease in volunteer blood donors.
    Alberti A; Chemello L; Cavalletto D; Tagger A; Dal Canton A; Bizzaro N; Tagariello G; Ruol A
    Ann Intern Med; 1991 Jun; 114(12):1010-2. PubMed ID: 1851402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus antibodies in dialysis pediatric patients.
    Di Loreto M; Ferrante M; Panaro A; Sorino P; Collela V; Caringella DA
    Nephron; 1992; 61(3):365-6. PubMed ID: 1323793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between ELISA and recombinant immunoblot assay in serum samples positive for anti-HCV.
    Lin HH; Hsu HY; Chang MH; Wang JT; Chen PJ; Chen DS
    J Formos Med Assoc; 1992 Jul; 91(7):729-30. PubMed ID: 1360305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to hepatitis C is common among patients with alcoholic liver disease with and without risk factors.
    Caldwell SH; Jeffers LJ; Ditomaso A; Millar A; Clark RM; Rabassa A; Reddy KR; De Medina M; Schiff ER
    Am J Gastroenterol; 1991 Sep; 86(9):1219-23. PubMed ID: 1652885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of anti-hepatitis C virus detection with ELISA assay and RIBA 4 in dialysis patients: our experience.
    Innocenti M; Mazzoni A; Moretti A; Palla P
    Nephron; 1992; 61(3):315. PubMed ID: 1380132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey.
    Serfaty L; Giral P; Elghouzzi MH; Jullien AM; Poupon R
    Hepatology; 1993 Feb; 17(2):183-7. PubMed ID: 8381381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
    Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
    Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of hepatitis C virus antibody by first and second generation assays and polymerase chain reaction in patients with autoimmune chronic active hepatitis types I, II, and III.
    Mitchel LS; Jeffers LJ; Reddy KR; Cheinquer H; Coelho-Little E; Moreda R; Parker T; Silva M; Li XM; de Medina M
    Am J Gastroenterol; 1993 Jul; 88(7):1027-34. PubMed ID: 7686329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Confirmation of high prevalence of hepatitis C antibodies in hemodialysis patients by second generation immunoblot assay.
    Di Maggio A; Annicchiarico R; De Siati M; Marangi A; Montemurro NE; Loperfido A; Prusciano F; Scatizzi A
    Nephron; 1992; 61(3):347-9. PubMed ID: 1323787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.